MYD88 and diffuse large B-cell lymphoma: Whilst hotspot mutations such as MYD88 L265P are reliably called as driver mutations, the reported frequencies of some non-hotspot mutations, such as those affecting SOCS1 and DTX1, range from 0% to more than 15% across major DLBCL sequencing studies38–41.